Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers

Phase 1 Completed 64 enrolled Foresee Pharmaceuticals Co., Ltd. InClin, Inc. · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a study to Investigate the Safety, Tolerability, and Pharmacokinetics, of Single (including Food Effect) and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers.

Timeline

Start: 2024-04-16
Primary completion: 2024-09-20
Completion: 2024-09-20

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	FP-020	Unknown	100 mg	Oral

Indications

No indication recorded.